Description
Summary of the BVAC/ABCA program hosted by the general annual meeting of the BHS in Ghent, Friday January 25 2013
- You cannot add another "Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma" to your cart. View cart
Article: Summary of the BVAC/ABCA program hosted by the general annual meeting of the BHS in Ghent, Friday January 25 2013
€3.03
